RSV in Young Children During and After the COVID-19 Pandemic – Implications for Delaying the Age of First Infection

Zoe Hancock; Peter Muir; Paul North; Philip Williams; Nicholas Veasey; Adam H R Finn; Robin D Marlow

doi:10.1097/INF.0000000000004468

RSV in Young Children During and After the COVID-19 Pandemic – Implications for Delaying the Age of First Infection

Zoe Hancock, Peter Muir, Paul North, Philip Williams, Nicholas Veasey, Adam H R Finn, Robin D Marlow^*

^*Corresponding author for this work

Research output: Contribution to journal › Article (Academic Journal) › peer-review

1 Citation (Scopus)

20 Downloads (Pure)

Abstract

Nonpharmaceutical interventions introduced in the United Kingdom’s response to the COVID-19 pandemic disrupted the transmission of other childhood infections. We report changes in seasonality, age dynamics and severity of respiratory syncytial virus infections between 2019 and 2023. These data show the potential effects of delaying respiratory syncytial virus exposure and may provide insights for the implementation of treatments preventing infection during early infancy.

Original language	English
Pages (from-to)	e456-e459
Number of pages	4
Journal	Pediatric Infectious Disease Journal
Volume	43
Issue number	12
Early online date	26 Jun 2024
DOIs	https://doi.org/10.1097/INF.0000000000004468
Publication status	Published - 1 Dec 2024

Bibliographical note

Publisher Copyright:
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.

Access to Document

10.1097/INF.0000000000004468

Full-text PDF (accepted manuscript)
This is the accepted author manuscript (AAM) of the article which has been made Open Access under the University of Bristol's Scholarly Works Policy. The final published version (Version of Record) can be found on the publisher's website. The copyright of any third-party content, such as images, remains with the copyright holder.
Accepted author manuscript, 254 KBLicence: CC BY

Handle.net

Persistent link

Cite this

@article{e8a70c8613b546bda8ff555505780529,

title = "RSV in Young Children During and After the COVID-19 Pandemic – Implications for Delaying the Age of First Infection",

abstract = "Nonpharmaceutical interventions introduced in the United Kingdom{\textquoteright}s response to the COVID-19 pandemic disrupted the transmission of other childhood infections. We report changes in seasonality, age dynamics and severity of respiratory syncytial virus infections between 2019 and 2023. These data show the potential effects of delaying respiratory syncytial virus exposure and may provide insights for the implementation of treatments preventing infection during early infancy.",

author = "Zoe Hancock and Peter Muir and Paul North and Philip Williams and Nicholas Veasey and Finn, \{Adam H R\} and Marlow, \{Robin D\}",

year = "2024",

month = dec,

day = "1",

doi = "10.1097/INF.0000000000004468",

language = "English",

volume = "43",

pages = "e456--e459",

journal = "Pediatric Infectious Disease Journal",

issn = "0891-3668",

publisher = "Lippincott Williams and Wilkins",

number = "12",

}

TY - JOUR

T1 - RSV in Young Children During and After the COVID-19 Pandemic – Implications for Delaying the Age of First Infection

AU - Hancock, Zoe

AU - Muir, Peter

AU - North, Paul

AU - Williams, Philip

AU - Veasey, Nicholas

AU - Finn, Adam H R

AU - Marlow, Robin D

PY - 2024/12/1

Y1 - 2024/12/1

N2 - Nonpharmaceutical interventions introduced in the United Kingdom’s response to the COVID-19 pandemic disrupted the transmission of other childhood infections. We report changes in seasonality, age dynamics and severity of respiratory syncytial virus infections between 2019 and 2023. These data show the potential effects of delaying respiratory syncytial virus exposure and may provide insights for the implementation of treatments preventing infection during early infancy.

AB - Nonpharmaceutical interventions introduced in the United Kingdom’s response to the COVID-19 pandemic disrupted the transmission of other childhood infections. We report changes in seasonality, age dynamics and severity of respiratory syncytial virus infections between 2019 and 2023. These data show the potential effects of delaying respiratory syncytial virus exposure and may provide insights for the implementation of treatments preventing infection during early infancy.

U2 - 10.1097/INF.0000000000004468

DO - 10.1097/INF.0000000000004468

M3 - Article (Academic Journal)

C2 - 38920389

SN - 0891-3668

VL - 43

SP - e456-e459

JO - Pediatric Infectious Disease Journal

JF - Pediatric Infectious Disease Journal

IS - 12

ER -

RSV in Young Children During and After the COVID-19 Pandemic – Implications for Delaying the Age of First Infection

Abstract

Bibliographical note

Access to Document

Handle.net

Fingerprint

Cite this